8-K
Current Report
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000100
Exit or restructuring costs · Regulation FD disclosure
- Item 2.05 Costs associated with exit or disposal activities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading currentreportonform8-k2019.htm…